pharmaceuticals-and-healthcare

United States Genome Editing/Genome Engineering Market Report 2016


Published On : Oct 2016

Category : Biotechnology

No. of Pages : 118 pages

  • $3800
  • $7600

Please click below to avail discount on this report

Notes:
Sales, means the sales volume of Genome Editing/Genome Engineering
Revenue, means the sales value of Genome Editing/Genome Engineering

This report studies sales (consumption) of Genome Editing/Genome Engineering in United States market, focuses on the top players, with sales, price, revenue and market share for each player, covering
Thermo Fisher Scientific, Inc. (U.S.)
Merck KGAA (Germany)
Horizon Discovery Group Plc (U.K.)
Genscript Biotech Corporation (U.S.)
Sangamo Biosciences, Inc. (U.S.)
Integrated DNA Technologies, Inc (U.S.)
Lonza Group Ltd. (Switzerland)
New England Biolabs, Inc. (U.S.)
Origene Technologies, Inc. (U.S.)
Transposagen Biopharmaceuticals, Inc. (U.S.)

Split by product types, with sales, revenue, price, market share and growth rate of each type, can be divided into
CRISPR
TALEN
ZFN
Antisense
Other Technologies
Split by applications, this report focuses on sales, market share and growth rate of Genome Editing/Genome Engineering in each application, can be divided into
Cell Line Engineering
Animal Genetic Engineering
Plant Genetic Engineering
Other Applications
 

A massive portion of the overall impetus that players and markets associated with biotechnology are receiving, comes from the rapidly increasing government support. Developed economies are especially ahead of the game in terms of research and development, as well as the incorporation of ready products into the commercial markets. However, it should be noted that the average time to market for a standard biotechnology product is exceedingly higher than conventional medical products. Despite this, players are becoming ever ready to tackle the more promising fields in biotechnology, namely stem cell technology, nanotechnology, and genetic cloning. This field is poised to be an inseparable part of the healthcare industry, and is in need of heavy efforts on the research and development side.

The United states genome editing genome engineering market report 2016 is a very different market loaded with exceptional competitors and very specific customer and end user appeals. The improvement of innovations is additionally in high demand, with the developed economies demonstrating a more prominent consideration in the advancement of cutting edge advances than the developing economies. The report considers every such element while surveying the upcoming expected openings for players in the market over the coming years. It therefore converts the data presented into a matter of point of view, and offers the most ideal one for the market as far as getting favored by the key drivers and patterns influencing the market is concerned, while evading the hindrances that could prevent the advance of the players. The establishment for this investigation is made by getting the readers of this report familiar with the basic syntax of the market as it is important to completely comprehend its progression that the said entities are expected to promote themselves on.

The regional examination of the United states genome editing genome engineering market report 2016 can be depicted as a widely inclusive survey of the key locations, from the points of view of these locations as specified through their existing player base and the general end user reports for them. This is a doubly useful approach in market examination for the regional companies, as it helps them see precisely what their field of operation needs, as far as their end users are concerned. Moreover, investors will be able to figure out which organization they can pay special attention to when attempting to extend their investments profiles. Additionally, the level of detail with which every segment and region is depicted can build this report up to be a convenient guide for them with regards to enhancing their place in a particular region or country, or with regards to entering new market fruitfully over the coming years.

The competitive analysis presented in the report on the United states genome editing genome engineering market report 2016 can be an imperative device in the overall arsenal that a market player possesses. A careful learning and understanding of the competitive profiles and the contentions between players is a crucial bit of data needed by all market players, and it is the thing that this report gives to every client. The level of customization for every player takes into consideration an extraordinary standpoint for them, taking into account significantly more noteworthy data.

List of Tables and Figures

Figure Picture of Genome Editing/Genome Engineering
Table Classification of Genome Editing/Genome Engineering
Figure United States Sales Market Share of Genome Editing/Genome Engineering by Type in 2015
Figure CRISPR Picture
Figure TALEN Picture
Figure ZFN Picture
Figure Antisense Picture
Figure Other Technologies Picture
Table Application of Genome Editing/Genome Engineering
Figure United States Sales Market Share of Genome Editing/Genome Engineering by Application in 2015
Figure Cell Line Engineering Examples
Figure Animal Genetic Engineering Examples
Figure Plant Genetic Engineering Examples
Figure Other Applications Examples
Figure United States Genome Editing/Genome Engineering Sales and Growth Rate (2011-2021)
Figure United States Genome Editing/Genome Engineering Revenue and Growth Rate (2011-2021)
Table United States Genome Editing/Genome Engineering Sales of Key Manufacturers (2015 and 2016)
Table United States Genome Editing/Genome Engineering Sales Share by Manufacturers (2015 and 2016)
Figure 2015 Genome Editing/Genome Engineering Sales Share by Manufacturers
Figure 2016 Genome Editing/Genome Engineering Sales Share by Manufacturers
Table United States Genome Editing/Genome Engineering Revenue by Manufacturers (2015 and 2016)
Table United States Genome Editing/Genome Engineering Revenue Share by Manufacturers (2015 and 2016)
Table 2015 United States Genome Editing/Genome Engineering Revenue Share by Manufacturers
Table 2016 United States Genome Editing/Genome Engineering Revenue Share by Manufacturers
Table United States Market Genome Editing/Genome Engineering Average Price of Key Manufacturers (2015 and 2016)
Figure United States Market Genome Editing/Genome Engineering Average Price of Key Manufacturers in 2015
Figure Genome Editing/Genome Engineering Market Share of Top 3 Manufacturers
Figure Genome Editing/Genome Engineering Market Share of Top 5 Manufacturers
Table United States Genome Editing/Genome Engineering Sales by Type (2011-2016)
Table United States Genome Editing/Genome Engineering Sales Share by Type (2011-2016)
Figure United States Genome Editing/Genome Engineering Sales Market Share by Type in 2015
Table United States Genome Editing/Genome Engineering Revenue and Market Share by Type (2011-2016)
Table United States Genome Editing/Genome Engineering Revenue Share by Type (2011-2016)
Figure Revenue Market Share of Genome Editing/Genome Engineering by Type (2011-2016)
Table United States Genome Editing/Genome Engineering Price by Type (2011-2016)
Figure United States Genome Editing/Genome Engineering Sales Growth Rate by Type (2011-2016)
Table United States Genome Editing/Genome Engineering Sales by Application (2011-2016)
Table United States Genome Editing/Genome Engineering Sales Market Share by Application (2011-2016)
Figure United States Genome Editing/Genome Engineering Sales Market Share by Application in 2015
Table United States Genome Editing/Genome Engineering Sales Growth Rate by Application (2011-2016)
Figure United States Genome Editing/Genome Engineering Sales Growth Rate by Application (2011-2016)
Table Thermo Fisher Scientific, Inc. (U.S.) Basic Information List
Table Thermo Fisher Scientific, Inc. (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Figure Thermo Fisher Scientific, Inc. (U.S.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Merck KGAA (Germany) Basic Information List
Table Merck KGAA (Germany) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Merck KGAA (Germany) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Horizon Discovery Group Plc (U.K.) Basic Information List
Table Horizon Discovery Group Plc (U.K.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Horizon Discovery Group Plc (U.K.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Genscript Biotech Corporation (U.S.) Basic Information List
Table Genscript Biotech Corporation (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Genscript Biotech Corporation (U.S.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Sangamo Biosciences, Inc. (U.S.) Basic Information List
Table Sangamo Biosciences, Inc. (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Sangamo Biosciences, Inc. (U.S.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Integrated DNA Technologies, Inc (U.S.) Basic Information List
Table Integrated DNA Technologies, Inc (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Integrated DNA Technologies, Inc (U.S.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Lonza Group Ltd. (Switzerland) Basic Information List
Table Lonza Group Ltd. (Switzerland) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Lonza Group Ltd. (Switzerland) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table New England Biolabs, Inc. (U.S.) Basic Information List
Table New England Biolabs, Inc. (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table New England Biolabs, Inc. (U.S.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Origene Technologies, Inc. (U.S.) Basic Information List
Table Origene Technologies, Inc. (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Origene Technologies, Inc. (U.S.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Transposagen Biopharmaceuticals, Inc. (U.S.) Basic Information List
Table Transposagen Biopharmaceuticals, Inc. (U.S.) Genome Editing/Genome Engineering Sales, Revenue, Price and Gross Margin (2011-2016)
Table Transposagen Biopharmaceuticals, Inc. (U.S.) Genome Editing/Genome Engineering Sales Market Share (2011-2016)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Genome Editing/Genome Engineering
Figure Manufacturing Process Analysis of Genome Editing/Genome Engineering
Figure Genome Editing/Genome Engineering Industrial Chain Analysis
Table Raw Materials Sources of Genome Editing/Genome Engineering Major Manufacturers in 2015
Table Major Buyers of Genome Editing/Genome Engineering
Table Distributors/Traders List
Figure United States Genome Editing/Genome Engineering Production and Growth Rate Forecast (2016-2021)
Figure United States Genome Editing/Genome Engineering Revenue and Growth Rate Forecast (2016-2021)
Table United States Genome Editing/Genome Engineering Production Forecast by Type (2016-2021)
Table United States Genome Editing/Genome Engineering Consumption Forecast by Application (2016-2021)

Send an Enquiry

  • * :
  • * :
  • * :
  • * :
  • * :
  • :
  • * :
  • * indicates required field.

LATEST NEWS


Back To Top